chlorpromazine has been researched along with sulfamethoxazole in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (31.58) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 8 (42.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Bozkowa, K; Hofman, H; Piekarczyk, A; Prokopczyk, J; Wańkowicz, B | 2 |
| Chung, YH; Hanano, M; Iga, T; Nishigaki, R | 2 |
| Andreasen, PB; Døssing, M | 1 |
| Black, RE | 1 |
| Matsudaira, H; Searashi, Y; Takagi, I | 1 |
2 review(s) available for chlorpromazine and sulfamethoxazole
| Article | Year |
|---|---|
The prophylaxis and therapy of secretory diarrhea.
Topics: Anti-Infective Agents, Urinary; Antidiarrheals; Chloramphenicol; Chlorpromazine; Cholera; Diarrhea; Drug Combinations; Enterotoxins; Escherichia coli; Escherichia coli Infections; Fluid Therapy; Furazolidone; Humans; Sulfamethoxazole; Tetracycline; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Water-Electrolyte Balance | 1982 |
[Drug-induced cholestasis].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antineoplastic Agents; Antipsychotic Agents; Chlorpromazine; Cholestasis; Drugs, Chinese Herbal; Erythromycin; Humans; Immunosuppressive Agents; Penicillins; Sulfamethoxazole; Testosterone Congeners; Trimethoprim | 2007 |
17 other study(ies) available for chlorpromazine and sulfamethoxazole
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
[Binding capacity of some drugs to plasma proteins of newborns in comparison with adults (author's transl)].
Topics: Adult; Age Factors; Animals; Chlorpromazine; Fetal Blood; Humans; Infant; Infant, Newborn; Protein Binding; Rabbits; Sodium Salicylate; Sulfamethazine; Sulfamethoxazole; Sulfonamides | 1977 |
[The binding capacity of some drugs to plasma proteins of newborns in comparison with adults (author's transl)].
Topics: Adult; Age Factors; Animals; Blood Proteins; Chlorpromazine; Humans; Infant, Newborn; Pharmaceutical Preparations; Protein Binding; Rabbits; Sulfamethazine; Sulfamethoxazole | 1977 |
The mechanism of intestinal transport of sulfamethoxazole and the effect of chlorpromazine in rat everted intestine.
Topics: Animals; Biological Transport; Carbon Dioxide; Chlorpromazine; Dinitrophenols; Hydrogen-Ion Concentration; In Vitro Techniques; Intestinal Mucosa; Male; Potassium Cyanide; Rats; Rats, Inbred Strains; Sulfamethoxazole | 1985 |
Effect of chlorpromazine on intestinal absorption of sulfamethoxazole in rats.
Topics: Animals; Cell Membrane Permeability; Chlorpromazine; Hydrogen-Ion Concentration; Intestinal Absorption; Intestinal Mucosa; Kinetics; Male; Phospholipids; Proteins; Rats; Rats, Inbred Strains; Regional Blood Flow; Sulfamethoxazole | 1983 |
Drug-induced liver disease in Denmark. An analysis of 572 cases of hepatotoxicity reported to the Danish Board of Adverse Reactions to Drugs.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents, Urinary; Antidepressive Agents, Tricyclic; Antitubercular Agents; Benzodiazepines; Chemical and Drug Induced Liver Injury; Child; Chlorpromazine; Contraceptives, Oral; Denmark; Drug Combinations; Female; Halothane; Humans; Male; Middle Aged; Oxyphenisatin Acetate; Risk Management; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1982 |